Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2014-09-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Institute for Clinical Systems Improvement (ICSI) is a nonprofit organization with expertise in large-scale practice improvement at the state and national level. Largely funded by health organizations in Minnesota, ICSI has a sustainable model to translate evidence into practice, through clinical practice guidelines, shared decision making, and practice redesign. A partnership between these two organizations (ICSI and Mayo Clinic) may lead to a sustainable and innovative approach to the dissemination of evidence-based health information at the point of care.
The objective of the current study is therefore to leverage the expertise of these two organizations to compare the impact of an active to a passive dissemination and implementation strategy of the ShareEBM toolkit. The aim of the study is to disseminate evidence-based information through the use of decision aids during encounters. The overall purpose of the qualitative evaluation is to understand why decision aids were used more or less in certain practices and what factors contributed to or hindered this uptake.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Active Choice in the EHR to Promote Statin Therapy
NCT03271931
Focus on Values to Stimulate Shared Decisions
NCT03905369
Impact of Health Literacy on Outcomes and Effectiveness of Shared Decision Making Programs in Patients With Chronic Diseases
NCT01083862
Testing Decision Aids About Early Stage Prostate Cancer
NCT02053389
Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)
NCT04450914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Implementation of Share EBM Toolkit
Investigators led implementation of tailored activities and tactics (Shared EBM Toolkit) designed to promote the use of the decision aids in clinical encounters (i.e. journal clubs, value map streaming).
Active Implementation of ShareEBM Toolkit
Passive Implementation of Share EBM Toolkit
Locally supported dissemination of Shared EBM Toolkit designed to promote the use of the decision aids in clinical encounters.
Passive Dissemination of Share EBM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Implementation of ShareEBM Toolkit
Passive Dissemination of Share EBM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. At least 2 primary care clinicians committed to participate in the study. Clinicians are defined as any healthcare professional providing patient care (i.e., physicians, nurse practitioners, physician assistants, diabetes educators)
2. A designated site champion and support staff that can provide the support needed to conduct the study
3. An IRB approval from their institution or are covered under Mayo Clinic IRB
4. Leadership is committed to this research and has endorsed the study
* Any clinician caring for patients with a chronic condition and who has opportunities to discuss medication management with their patients will be deemed eligible
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Victor Montori
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Victor Montori, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Park Nicollet- Brookdale
Brooklyn Center, Minnesota, United States
Ridgeview Medical Center
Delano, Minnesota, United States
Essentia Health-Lakeside Clinic
Duluth, Minnesota, United States
Fairview Clinic-Eagan
Eagan, Minnesota, United States
Park Nicollet-Golden Valley
Golden Valley, Minnesota, United States
Essentia Hermantown Clinic
Hermantown, Minnesota, United States
Native American Community Clinic
Minneapolis, Minnesota, United States
Community Health Service, Inc.
Rochester, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
Fairview Medical-Rosemount
Rosemount, Minnesota, United States
Baldwin Area Medical Center, Inc.
Baldwin, Wisconsin, United States
Hudson Physicians S.C.
Hudson, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-002055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.